Cargando…
Heparin-Binding Epidermal Growth Factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia
Pancreatic cancer remains one of the most deadly cancers with few treatment options at late stages and little information about how it develops through earlier stages. Activating mutation of the Kras gene has been implicated in, but is not sufficient for, tumorigenesis. In mouse models of pancreatic...
Autores principales: | Ray, Kevin C., Moss, Mary E., Franklin, Jeffery L., Weaver, Connie J., Higginbotham, James, Song, Yan, Revetta, Frank L., Blaine, Stacy A., Bridges, L. Richard, Guess, Katherine E., Coffey, Robert J., Crawford, Howard C., Washington, M. Kay, Means, Anna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929321/ https://www.ncbi.nlm.nih.gov/pubmed/23376846 http://dx.doi.org/10.1038/onc.2013.3 |
Ejemplares similares
-
Control Growth Factor Release Using a Self-Assembled [polycation∶heparin] Complex
por: Zern, Blaine J., et al.
Publicado: (2010) -
Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012) -
Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023) -
Active Kras Expression in Gastric Isthmal Progenitor Cells Induces Foveolar Hyperplasia but Not Metaplasia
por: Choi, Eunyoung, et al.
Publicado: (2018) -
Locally administered heparin-binding epidermal growth factor-like growth factor reduces radiation-induced oral mucositis in mice
por: Chen, Jing, et al.
Publicado: (2020)